Abstract Using an immunocytochemical staining assay involving six different recombinant baculoviruses with each expressing one of the major bovine rotavirus VP7 (G6, G8 and G10) and VP4 [1974][1975] in Higley, Arizona. Seroresponses to VP7 and VP4, as determined by a fourfold or greater antibody response, were not always elicited concurrently following infection: in some calves, (1) seroresponses to VP7 were detected earlier than to VP4 or vice versa; and (2) a subsequent second seroresponse was detected for VP7 or VP4 only. In addition, a second infection was more likely to be caused by different G and/or P types. Analyses of serum samples showed that the most frequent G-P combination was G8P6[1], followed by G8P7[5], G8P8[11] and G6P6 [1] .
Introduction
Group A rotaviruses, members of the genus Rotavirus within the family Reoviridae, are a common cause of acute infectious diarrheal illness in infants and the young of a wide variety of mammalian and avian species [14] . Bovine rotaviruses are important causative agents of neonatal calf diarrhea throughout the world, and rotavirus infection is a significant cause of economic loss in the cattle industry [58] . The rotavirus genome, which consists of 11 segments of double-stranded RNA (dsRNA), encodes six structural viral proteins (VP1-4, 6 and 7) and six non-structural viral proteins (NSP1-6) [14] . Outer capsid proteins VP7 and VP4, which are each independent neutralization and protective antigens, define VP7 or G serotype/genotype and VP4 or P serotype/genotype, respectively [14] . A total of 15 G genotypes and 27 P genotypes have been detected in humans and animals combined [14, 42] . At least nine G (G1, G2, G3, G6, G7, G8, G10, G11 and G15) and six P genotypes (P [1] , P [5] , P [11] , P [14] , P [17] and P[21]) have been detected in cattle thus far. Among them, G genotypes G6, G8 and G10, and P genotypes P [1] , P [5] , and P [11] are of epizootiologic importance worldwide [11, 20, 49, 52, 53, 62] . Bovine rotaviruses detected in early studies have played a significant role in research and development of human rotavirus vaccines. For example, (1) US bovine rotavirus strain NCDV (G6P6 [1] ) [44] was the first human rotavirus vaccine which was evaluated extensively in clinical trials [58, 68, 69] ; (2) British bovine rotavirus strain UK (G6P7 [5] ) [6] is a parental strain of the humanbovine reassortant rotavirus vaccine [31, 45, 46] , which is currently under development in India, China, and Brazil [25, 37] ; and (3) US bovine rotavirus strain WC3 (G6P7 [5] ) is a parental strain of a human-bovine reassortant vaccine which was licensed in the US in 2006 as well as in other countries [25] .
A variety of techniques have been utilized to measure rotavirus-specific serum antibody responses in cattle including a neutralization assay [7, 8, 10, 23, 39, 57, 61, 63, [70] [71] [72] [73] [74] , ELISA [39, 48, 57, 72] , an epitope-blocking immunoassay [63] , a radioimmunoassay [1, 2] and an immunocytochemical staining assay [75] . The immunocytochemistry staining assay that uses Sf-9 insect cells infected with recombinant baculovirus expressing selected rotavirus proteins as immobilized antigens to detect protein-specific antibody responses has been well established to be rapid, simple, sensitive, and specific [33, 34, 75, 76] . More importantly, in this assay, unlike a radioimmunoprecipitation assay and western blot (immunoblot) assay, antibodies to complex, conformation-dependent antigenic epitopes on both VP4 and VP7 protective antigens can be measured [33, 34] .
Previously, we reported homotypic and heterotypic serum IgG antibody responses to a total of seven different NSP4 proteins in gnotobiotic calves infected orally or intraamniotically with bovine rotavirus [75] . In the present study, using the immunocytochemical staining assay involving a total of six different recombinant baculoviruses with each expressing one of the major bovine rotavirus VP7 (G6, G8 or G10) and VP4 (P6 [1] , P7 [5] or P8 [11] ) serotypes, we quantified IgG antibodies to individual proteins in archival serum samples collected from a cohort of 31 calves in an attempt to analyze the frequency and patterns of rotavirus infections and the distribution of G and P types of infecting rotaviruses.
Materials and methods

Serum samples
The project was initiated in 1974 by Dr. Francis R. Abinanti of the University of Arizona, Department of Veterinary Science, in collaboration with Dr. Albert Z. Kapikian of the National Institutes of Health to study the epidemiology and natural history of bovine rotaviruses in calves. Sequential serum samples were obtained from 31 Holstein calves at approximately monthly intervals from 1 to 12 months of age during the 1974-1975 season at the Arizona Dairy Company located in Higley, Arizona. The calves were given colostrum immediately after birth from the dam of each calf and raised separately from their mothers. The serum samples sent to NIH were stored in a -20°C freezer until testing. These samples were evaluated for rotavirus infection by complement fixation test (CFT) [36] using the ''O'' agent and the bovine NCDV strain in the mid-1970s at NIH (unpublished data). A total of 309 serum samples were analyzed in the current study.
Construction of recombinant baculoviruses expressing rotavirus VP4 or VP7 protein Recombinant baculoviruses with each expressing one of the major bovine rotavirus VP4 (P6 [1] , P7 [5] and P8 [11] ) or VP7 (G6, G8 and G10) proteins (Table 1) were constructed according to the manufacturer's instructions or as described elsewhere [76] . The expression of a rotavirus protein was confirmed by western blot analysis against type-specific polyclonal antibodies to the rotavirus protein.
High-titer virus stocks of the recombinant baculoviruses were propagated in Sf-9 insect cells, and their titers were determined by using a plaque assay according to the manufacturer's instructions (Bac-N-Blue Transfection Kit, Invitrogen).
Immunocytochemistry (Sf-9 insect cell staining) assay Titers of serum IgG antibodies to each of the recombinant rotavirus VP4 and VP7 proteins were determined using an Sf-9 insect cell staining assay as previously described [33, 34, 75, 76] . Briefly, Sf-9 insect cells were infected with baculovirus expressing individual rotavirus proteins at an MOI of 0.1 and seeded onto 96-well tissue culture plates (Costar, Corning Inc., NY), and the plates were incubated for 72 h at 28°C. The culture medium was then removed and plates were air-dried in a biosafety cabinet at room temperature for 1 h. Cells were then fixed with 10% formalin (Sigma, St. Louis) for 30 min and permeabilized with 1% Triton X-100 (Sigma) in TNC (10 mM Tris, 100 mM NaCl, 1 mM CaCl 2 [pH 7.4]) for 2 min. After two 
Seroresponse indexes
Protein-specific IgG antibody titers against each VP7 (G) or VP4 (P) type were converted to a seroresponse index representing the fold increase in antibody titer in paired sera that were collected sequentially in a given period of 1 or 2 months from each calf. A fourfold or greater seroresponse index to the specific antigen (e.g., G6 VP7 protein) that was detected in a given serum pair was considered to indicate that the calf (from which the paired sera were derived) was infected with a rotavirus bearing that specific antigen (e.g., G6 specificity) during that period of 1 or 2 months.
Statistical analysis
Geometric mean serum IgG antibody titers to each VP7 or VP4 protein in calves that experienced the first seroresponse either before or C4 months of age were analyzed using Student's t test with SPSS 14.0 package (SPSS Inc.). Statistical significance was assessed at P \ 0.05.
Results
Frequency and patterns of serum IgG antibody seroresponse to protective antigens VP7 and VP4
Each of 31 calves experienced at least one rotavirus infection as determined by a fourfold or greater G and/or P serotype-specific antibody response during the period of 12 months. Twenty-nine of the 31 (93.6%) calves had at least one rotavirus infection as determined by CFT (data not shown). The first G and/or P serotype-specific seroresponse was detected between 2 and 8 months of age ( Fig. 1 ): a seroresponse was not detected after 9 months of age. Since serum samples collected at birth were not available, we could not determine seroresponse in calves during the 1st month of life. The influence of preexisting antibodies at 1 month of age on the timing of a seroresponse was variable for different serotypes (Fig. 2 ). For example, calves that experienced a seroresponse between 2 and \4 months of age to 69M (G8), B223 (G10) or B223 (P8 [11] ) had significantly lower IgG antibody titers at 1 month of age, whereas those that experienced a seroresponse between 2 and \4 months of age to UK (G6), UK (P7 [5] ) or NCDV (P6 [1] ) did not (Fig. 2) .
Of note was the finding that VP4-and VP7-specific seroresponses were not always elicited concurrently in calves following infection. Only 25.8% of calves developed concurrent VP4-and VP7-specific seroresponses, whereas 45.2% of calves had a VP4-specific seroresponse prior to that to VP7, and 29.0% of calves exhibited VP7-specific seroresponse prior to that to VP4. Figure 3 represents longitudinal serum IgG antibody profiles to three VP7 proteins (UK G6, 69M G8 and B223 G10) and three VP4 proteins (UK P7 [5] , NCDV P6 [1] and B223 P8 [11] ) of two calves: one that experienced a single rotavirus infection and another (case #2 in Table 3 ) that experienced repeated rotavirus infections. It was noteworthy that existing antibody levels at 1 month of age varied depending upon G and/or P type(s). Both calves exhibited a decline in antibody titers to selected G and/or P proteins during the first 5 months of age, which may have reflected the decrease of maternally derived antibodies in the calves to such proteins. One calf developed a seroresponse to P7 [5] VP4 at 6 months of age as well as a seroresponse to both G6 and G8 VP7s at 9 months of age (Fig. 3a) .
Another calf demonstrated the first seroresponse to P8 [11] VP4 at 4 months of age and the second seroresponse to P6 [1] and P7 [5] VP4s at 10 months of age. Of note was the finding that the first seroresponse to VP7 (G8) was not detected in this calf until 12 months of age (Fig. 3b) .
Frequency of rotavirus infections and distribution of G and P types of infecting rotaviruses Table 3 ) that experienced repeated rotavirus infections (b) frequent G-P combination of infecting rotavirus was G8P6 [1] , followed by G8P7 [5] , G8P8 [11] and G6P6 [1] . Thus, our retrospective analyses of serum samples showed that G8 and P6 [1] were the predominant bovine rotavirus types infecting cattle during the 1974-1975 season, in Higley, Arizona.
Repeated rotavirus infections
Twenty of 31 (64.5%) calves experienced repeated rotavirus infections as determined by the immunocytochemical staining assay; 12 of the 20 were detected by the CFT also, and in addition, one infection was detected by the CFT only (Table 3) . Of note was the finding that in each of the 20 calves, the primary rotavirus infection was identified by both G type and P type-specific seroresponses to the infecting rotavirus(es), whereas only 4 of the 20 (20.0%) second rotavirus infections were identified by both G type and P type specific seroresponses. The distribution of seroresponses among the 11 calves that did not respond to both VP7 and VP4 was as follows: 5 developed a G typespecific seroresponse and 11 a P type-specific seroresponse. These varying patterns of second seroresponses may reflect the influence of relative concentrations of VP7-and/or VP4-specific antibodies present in calves at the time of second rotavirus infection(s) that were induced by the primary infections. It is of interest that each of the 21 initial seroresponses was detected by the CFT using the ''O'' 
12 agent, whereas only 9 of the 21 responses were detectable by using the NCDV strain (Table 3) . However, 8 and 9 of the second seroresponses were detected by using the ''O'' agent and the NCDV strain, respectively. Recently, the ''O'' agent was shown to bear a G8P [1] specificity [60] , which may, in part, be associated with the observed efficient detectability of the first seroresponse with the ''O'' agent; 14 of the 21 responses were deduced to be caused by the G8 or G8 plus other G types.
Only two of the 8 (25%) second G type seroresponses and two of the 15 (13.3%) second P type seroresponses were shown to be caused by the same G type and P type, respectively. These percentages were lower than those caused by the different G type and P type (X 2 = 3.96, P = 0.047), suggesting that protection against rotavirus reinfection was primarily homotypic.
Discussion
In the present study, we had a rare opportunity to analyze rotavirus-specific antibodies in archival serum samples (n = 309) collected monthly from 1 month to 1 year of age from a cohort of 31 calves during the 1974-1975 season in Higley, Arizona. This was possible because such serum samples, which were sent from the University of Arizona, College of Agriculture, to the NIH in the mid1970s, were still available after storage at -20°C. Although the bovine rotavirus NCDV strain was one of the earliest group A rotaviruses that was cell culture-adapted and characterized [44], it was not possible to routinely identify G and P types of field bovine isolates until the mid1990s when Gouvea et al. [27, 28] reported the development of a PCR typing methodology for bovine rotavirus G and P genotypes. Bovine rotavirus strain surveillance studies using such a methodology have established that G genotypes G6, G8 and G10 and P genotypes P [1] , P [5] and P [11] are of epizootiologic importance worldwide. In the present study, we generated baculovirus recombinants expressing each of the three major G genotypes (G6, G8 and G10) and P genotypes (P [1] , P [5] and P [11] ) and, by using these recombinants in immunocytochemistry assays, analyzed IgG antibody responses to each protein in the 309 calf serum samples from Arizona.
Although each of the 31 calves experienced at least one rotavirus infection as determined by a fourfold or greater G or P serotype-specific antibody response during the 12-month-period, it was unexpected to find that only 7 (22.6%) of the calves were infected with a single rotavirus strain. The mixed infection rate of 77.4% was considerably greater than the rate of B48.5% reported previously [3, 19, 35, 54, 62, 64] . Although the identification of rotavirus infections can be detected by examination of stools and/or by serologic responses, in general, the latter are more efficient. In one study [67] , a serologic assay identified 77.0% of rotavirus infections in a cohort of 200 children monitored from birth to 2 years of age, whereas analysis of shedding of virus in stools identified only 56% of rotavirus infections in the same group of children. Thus, it was not surprising that we identified serologic evidence of rotavirus infection in all of the 31 calves that might have experienced either a symptomatic or an asymptomatic infection. On the other hand, both RT-PCR genotyping and/or monoclonal antibody-based ELISA that were utilized in published reports [18-22, 24, 27, 28, 32, 54] analyzed only a single stool sample from each calf that was diarrheic.
It is conceivable that some of the mixed G and/or P type seroresponses identified in this study were not caused by actual G and/or P type mixed infections but rather reflected a broadening of the immune response after repeated infections [9, 10, 26, 61, 63, 67] . A limitation of this study was that since the calf stool samples were not available, the detection and genotyping of infecting rotaviruses in stools were not performed. Such analysis would have validated the designation of repeated infections based on seroresponses to additional serotypes. It is noteworthy that (1) in contrast to the high rate of a second seroresponse to VP4 proteins (55%), such a response to VP7 proteins (25%) was significantly lower (X 2 = 6.45, P = 0.04), and (2) the rate of seroresponse to multiple P types (54.8%) was significantly higher than that to multiple G types (32.3%) (X 2 = 7.33, P = 0.03). These findings may reflect the greater crossreactivity of VP4 proteins when compared to VP7 proteins [12, 13, 50] . It is interesting to note that although several monoclonal-antibody-based G serotyping ELISA kits are commercially available, none is available for P serotyping, likely because monoclonal antibodies to the VP4 are, in general, broadly P type cross-reactive [12, 13, 50] .
Of note was the finding that calves that experienced their first seroresponse between 2 and \4 months of age had a significantly lower antibody titer to certain serotypes at 1 month of age than those that developed a seroresponse later (Fig. 2) , suggesting that maternal antibody might play a role in delaying primary infections and/or the development of antibody responses, as observed in gnotobiotic pigs [30, 51] . The transfer of circulating maternal serum IgG antibody (which is originally derived from colostrum) to the gastrointestinal tract in young calves has been well documented [4, 5, 16, 40] . Furthermore, the decrease in clinical signs or the protection from rotavirus infections associated with maternally derived high levels of serum IgG antibodies in neonatal calves have been reported previously [4, 5, 56] .
Another interesting finding was that VP4-and VP7-specific seroresponses were not always elicited concurrently in rotavirus-infected calves. In addition, in some calves, a second seroresponse was detected for a G type(s) or for a P type(s) only. This may be a function of G or P type-specific antibodies in the calf small intestine at the time of rotavirus infection, which were derived from dams via colostrum or induced by primary rotavirus infections [4, 5, 30, 40] .
Although the virus bearing a G6P6 [1] specificity is used in most commercial bovine vaccines [3, 66] , the most commonly detected bovine rotavirus genotype in many countries appears to be G6P [5] [3, 18, 19, 24, 35, 54, 62, 64] . In this retrospective analysis, serotype G8 was shown to be the predominant bovine rotavirus G type in the Higley, Arizona area during the 1974-1975 season. Serotype G8 virus was first recovered from a child with gastroenteritis in Indonesia in 1984 [29, 43] . The first bovine G8 strain was isolated in Scotland in 1984 also [47, 62] . Later, it was detected in North America and other countries [18, 19, 41, 49, 52, 65] , and it appears to be epidemiologically important today in parts of Africa [59] . Various reports [18, 24, 49, 62] appear to indicate that G8 is one of the less common serotypes among bovine rotaviruses; however, the G8 has been reported to be the predominant G type in cattle in some parts of the world during certain periods of time [15, 17, 19] . Interestingly, retrospective analyses reported in 1995 demonstrated [41] that the bovine Cody strain (NCDV-Cody) isolated in Nebraska in 1968, which was thought initially to be the virulent counterpart for the attenuated NCDV strain (NCDV-Lincoln, G6P [1] ), bore a G8P [1] specificity. Thus, that report and our current data indicate that the bovine G8 serotype has been circulating among cattle in the USA for more than 3 decades.
Our analyses of VP7-and VP4-specific antibody responses in calves indicated that (1) repeated infections were less likely to be caused by the G and/or P types than those caused by primary infections (X 2 = 3.96, P = 0.047), and (2) protection against rotavirus reinfection tended to be serotype-specific. A similar trend (i.e., second infections were more likely to be caused by another G type) was also observed in a cohort study involving 200 Mexican infants monitored weekly for rotavirus excretion and diarrhea from birth to age 2 years [67] . In a recent largescale, double-blind, placebo-controlled trial of more than 63,000 infants enrolled in 11 Latin American countries and Finland, the monovalent G1P [8] vaccine (RIX4414) proved to be strongly efficacious in preventing rotavirus diarrhea of any severity caused by the G and/or P typehomotypic viruses (i.e., G1P [8] , G3P [8] , G4P [8] , and G9P [8] ); however, efficacy against the G and P type heterotypic virus (i.e., G2P [4] ) was not significant [55] . Although there is still considerable disagreement on the role and importance of serotype-specific immunity in protection against rotavirus-caused illness [38] , our data support the strategy of the administration of a multivalent vaccine and multiple vaccinations in order to elicit broader protection against prevailing serotypes in humans [67] .
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